Contents: Rabeprazole Na
Indications: Active duodenal ulcer, active benign gastric ulcer, anastomotic ulcer, erosive or ulcerative GERD, GERD maintenance, symptomatic treatment of moderate to very severe GERD, Zollinger-Ellison syndrome & other pathological hypersecretory conditions, eradication of H. pylori in patients w/ PUD.
Contraindications: Hypersensitivity to rabeprazole Na & substituted benzimidazoles. Pregnancy & lactation.
Dosage: Adult/elderly Active duodenal ulcer, active benign gastric ulcer, anastomotic ulcer 10 or 20 mg once daily in the morning. Erosive or ulcerative GERD 10 or 20 mg once daily for 4-8 wk. Doses of 10 or 20 mg bid may be administered for another 8 wk in reflux esophagitis patients who are not responding to the usual dose of proton pump inhibitors. However, a dose of 20 mg bid should only be administered to patients w/ severe mucosa injury. GERD maintenance 10 or 20 mg once daily depending upon patient response. Symptomatic GERD 10 mg once daily for patients w/o esophagitis. If symptom control has not been achieved after 4 wk, the patient should be further investigated. Zollinger-Ellison syndrome & other pathological hypersecretory conditions Initially 60 mg daily, increase up to 100 mg once daily or 60 mg bid. Eradication of H. pylori in patient w/ PUD 10 or 20 mg of Pariet w/ clarithromycin 500 mg & amoxicillin 1 g all bid for 7 days.
Administration: May be taken with or without food: Swallow whole, do not chew/crush.
Regulatory Classification: Rx
Manufacturer: Eisai
Distributor: Zuellig / HI-Eisai
